ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study

March 6, 1992

Richard Pazdur’s Comments to ODAC

July 22, 2011

ASCO Updates Clinical Recommendations On Use Of Bisphosphonates In Myeloma

May 25, 2007

NIH advisors Review Intramural Program, Plan Spring Report

December 10, 1993

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980